Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson’s Disease-Related LRRK2 G2019S Mutation
Andrew J. Schwab, Allison D. Ebert
Stem Cell Reports (2015) Vol. 5, Iss. 6, pp. 1039-1052
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

New insights into the complex role of mitochondria in Parkinson’s disease
Anne Grünewald, Kishore R. Kumar, Carolyn M. Sue
Progress in Neurobiology (2018) Vol. 177, pp. 73-93
Open Access | Times Cited: 332
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Jenne Tran, Helena Targa Dias Anastacio, Cédric Bardy
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 143
Studying human nociceptors: from fundamentals to clinic
Steven J. Middleton, Allison M. Barry, Maddalena Comini, et al.
Brain (2021) Vol. 144, Iss. 5, pp. 1312-1335
Open Access | Times Cited: 108
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 144
iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates
Alex Laperle, Samuel Sances, Nur Yucer, et al.
Nature Medicine (2020) Vol. 26, Iss. 2, pp. 289-299
Closed Access | Times Cited: 114
LRRK2 and mitochondria: Recent advances and current views
Alpana Singh, Lianteng Zhi, Hui Zhang
Brain Research (2018) Vol. 1702, pp. 96-104
Open Access | Times Cited: 110
Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons
Andrew J. Schwab, Samantha L. Sison, Michael R. Meade, et al.
Stem Cell Reports (2017) Vol. 9, Iss. 6, pp. 1839-1852
Open Access | Times Cited: 81
The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain
Sven H. Schmidt, Matthias J. Knape, Daniela Boassa, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 30, pp. 14979-14988
Open Access | Times Cited: 73
Neurite Collapse and Altered ER Ca2+ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation
Joanna A. Korecka, Sébastien Talbot, Teresia Osborn, et al.
Stem Cell Reports (2018) Vol. 12, Iss. 1, pp. 29-41
Open Access | Times Cited: 69
Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy
Samantha L. Sison, Teresa N. Patitucci, Emily R. Seminary, et al.
Human Molecular Genetics (2017) Vol. 26, Iss. 17, pp. 3409-3420
Open Access | Times Cited: 67
Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects
Laurence Borgs, Elise Peyre, Philippe Alix, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 62
Calcium signalling: A common target in neurological disorders and neurogenesis
Talita Glaser, Vanessa Fernandes Arnaud-Sampaio, Claudiana Lameu, et al.
Seminars in Cell and Developmental Biology (2018) Vol. 95, pp. 25-33
Closed Access | Times Cited: 59
Electrophysiological Phenotype Characterization of Human iPSC‐Derived Neuronal Cell Lines by Means of High‐Density Microelectrode Arrays
Silvia Ronchi, Alessio Paolo Buccino, Gustavo Prack, et al.
Advanced Biology (2021) Vol. 5, Iss. 3
Open Access | Times Cited: 44
Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
Padmashri Naren, Anjali Cholkar, Suchita N. Kamble, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S399-S428
Open Access | Times Cited: 28
Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?
Janelle Drouin‐Ouellet, Karolina Pircs, Roger A. Barker, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 50
Recent Developments in LRRK2-Targeted Therapy for Parkinson’s Disease
Ye Zhao, Nicolas Dzamko
Drugs (2019) Vol. 79, Iss. 10, pp. 1037-1051
Closed Access | Times Cited: 50
Human Cytomegalovirus Disruption of Calcium Signaling in Neural Progenitor Cells and Organoids
Samantha L. Sison, Benjamin S. O’Brien, Amanda Johnson, et al.
Journal of Virology (2019) Vol. 93, Iss. 17
Open Access | Times Cited: 49
Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis
Jungwoo Wren Kim, Xiling Yin, Aanishaa Jhaldiyal, et al.
Cell stem cell (2020) Vol. 27, Iss. 4, pp. 633-645.e7
Open Access | Times Cited: 49
In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson’s Disease in Common Marmosets
Scott Vermilyea, Alexander Babinski, Nina Tran, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 41
Human Induced Pluripotent Stem Cell Derived Sensory Neurons are Sensitive to the Neurotoxic Effects of Paclitaxel
Chenling Xiong, Katherina C. Chua, Tore Bjerregaard Stage, et al.
Clinical and Translational Science (2020) Vol. 14, Iss. 2, pp. 568-581
Open Access | Times Cited: 40
Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models
Marina Trombetta-Lima, Angélica María Sabogal-Guáqueta, Amalia M. Dolga
Cell Calcium (2021) Vol. 94, pp. 102362-102362
Open Access | Times Cited: 37
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Domenico Cieri, Marisa Brini, Tito Calì
Biochemical and Biophysical Research Communications (2016) Vol. 483, Iss. 4, pp. 1020-1030
Closed Access | Times Cited: 46
Targeting LRRK2 in Parkinson’s disease: an update on recent developments
Sharon L. Chan, Eng‐King Tan
Expert Opinion on Therapeutic Targets (2017) Vol. 21, Iss. 6, pp. 601-610
Closed Access | Times Cited: 45
Genetic Modifiers of Neurodegeneration in a Drosophila Model of Parkinson’s Disease
Sierra Lavoy, Vinita G. Chittoor-Vinod, Clement Y. Chow, et al.
Genetics (2018) Vol. 209, Iss. 4, pp. 1345-1356
Open Access | Times Cited: 42
Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
Samantha L. Sison, Scott Vermilyea, Marina E. Emborg, et al.
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 12
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top